TH Global Capital advises Healthcare Design and Innovation Consultancy Worrell Design on its sale to Veranex

Dec 2021
Has been acquired by

MedTech Design & Innovation Consulting

View Transaction Details
TH Global Capital advises Healthcare Design and Innovation Consultancy Worrell Design on its sale to Veranex
Seller Worrell Design
Buyer Veranex
Focus Sector MedTech Design & Innovation Consulting
Date December 2021

TH Global Capital is pleased to announce the strategic sale of Worrell, a healthcare design, innovation and product engineering firm, to Summit Partners-backed Veranex Solutions.

quote We are pleased to have chosen TH Global Capital as the advisory firm to work with us to find the right strategic fit. As a design and innovation services firm that focuses exclusively on healthcare, together with Veranex we can now offer a broader array of services to meet a growing demand from our clients. This year is shaping up to be a record year for our firm and Veranex is well positioned to help us sustain and accelerate our growth trajectory. We couldn't be more pleased with the TH Global Capital team, their understanding of the market and their process that delivered such a great outcome for us.
Kai Worrell Chief Executive Officer

Headquartered in Minneapolis, with offices in London and Shanghai, Worrell provides research & strategy, digital design, product engineering and human factors consulting services to 24 of the largest 40 medical device, life sciences and biotech companies.

TH Global Capital acted as the sell side adviser to Worrell, and this is our third successful healthcare design and product engineering transaction in the last 3 years. Founded in 2021 with the acquisitions of five platform companies, Veranex is the first company exclusively focused on providing concept-to-commercialization services for medical technology companies. Together, Veranex and Worrell provide best-in-class design and engineering, market access, data management, medical device evaluation, as well as clinical, quality and regulatory expertise, to help healthcare companies develop products that bring value to patients and providers worldwide. The combined client roster includes some of the largest global medical device and life sciences companies such as Novartis, Roche, Boston Scientific and Medtronic. Worrell’s product engineering services will enable Veranex to better engage with clients during the initial phases of a product development lifecycle.

Vivek Subramanyam, CEO of TH Global Capital said “As companies across the healthcare continuum embrace a culture of innovation to improve patient outcomes, the need for specialized digital and product engineering capabilities will continue to drive M&A appetite in the market, both from strategic and financial investors. TH Global Capital’ focus on digital transformation, design, innovation and product engineering is a differentiator for digital and human-centered design companies looking for growth opportunities.”

About Veranex
Veranex is the only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology industry. Offering expert guidance from concept through to commercialization and across the development continuum, Veranex enables accelerated speed to market, controlled development costs, development risk mitigation, and accelerated market viability assessment. At every stage, Veranex customers realize efficiencies in cost and time, while its integrated and comprehensive solutions unify the entire development process. For more information, visit VeranexSolutions.com.

About Worrell
Worrell is a product design, development and strategy firm that works with 24 of the 40 largest medical device, life sciences and biopharma companies to improve lives globally through design. Worrell has expertise in product design, engineering, digital experience, human factors and FDA compliance.

Transactions
Aug 2024
france
Has been acquired by

MedTech Product Design Consulting & Engineering

View Transaction Details
TH Global Capital advises Design + Industry, a leading MedTech Product Design and Engineering consultancy, on its strategic sale to Capgemini
May 2023
Has been acquired by

Life Sciences Commercialization & Marketing

View Transaction Details
TH Global Capital advises The Kinetix Group, a Life Sciences Commercialization and Marketing company, on its sale to Petauri Health
Mar 2023
united-states
TH Global Capital is pleased to announce that it has acted as the exclusive financial advisor to SUAZIO, a leading data-driven Life Sciences and MedTech consultancy on its strategic sale to NAMSA, the world's leading MedTech CRO, an Archimed portfolio company headquartered in the United States.
Has been acquired by

Life Sciences & MedTech Consulting

View Transaction Details
TH Global Capital advises SUAZIO, A Data-Driven Life Sciences and MedTech Strategic Consultancy, on its strategic sale to NAMSA
Dec 2021
Has been acquired by

MedTech Design & Innovation Consulting

View Transaction Details
TH Global Capital advises Healthcare Design and Innovation Consultancy Worrell Design on its sale to Veranex
Feb 2021
united-states
Has been acquired by

Life Sciences Omnichannel Consulting & Insights IP

View Transaction Details
TH Global Capital advises Omnichannel Life Sciences leader, Across Health, on its strategic sale to Precision Medicine Group
Aug 2019
france
Has been acquired by

Healthcare Innovation Consulting

View Transaction Details
TH Global Capital advises healthcare innovation consultancy, Insight Product Development, on its strategic sale to Nemera
Dec 2018
Has been acquired by

Strategic Healthcare Marketing Consultancy

View Transaction Details
TH Global Capital advises leading strategic healthcare marketing consultancy, Blue Latitude Health on its strategic sale to Fishawack
Mar 2018
Has been acquired by

Design, Innovation & MedTech Consulting

View Transaction Details
TH Global Capital advises design & innovation consultancy Continuum on its strategic sale to Epam
Jan 2016
Has been acquired by

Healthcare Analytics Software

View Transaction Details
TH Global Capital advises SCIO Health Analytics on its acquisition of Clear Vision Information Systems
Mar 2015
india
Has been acquired by

Care Management & Wellness Automation

View Transaction Details
Jan 2015
united-kingdom
Has been acquired by

Life Sciences Analytics

View Transaction Details
TH Global Capital is pleased to announce that our client SCIO Health Analytics has completed the acquisition of Data Intelligence
Nov 2014
Has been acquired by

Healthcare Revenue Cycle Management

View Transaction Details
TH Global Capital advises Millennium Practice Management Associates on its acquisition by Medigain Services, Inc.
Feb 2011
Has been acquired by

Health Claims Audit & Recovery

View Transaction Details
Jun 2008
Has been acquired by

Healthcare Analytics & Consulting

View Transaction Details
May 2008
Has been acquired by

Payor Subrogation

View Transaction Details
Aug 2007
india
Has been acquired by

Medical Billing & Practice Management

View Transaction Details
May 2005
singapore
Pvt Equity investment

Healthcare IT & BPO

View Transaction Details
WhatsApp LinkedIn